VAIDYA SANE AYURVED LABORATORIES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165 INR | -3.54% |
|
-13.16% | -22.02% |
| Sales 2022 | 747M 8.97M | Sales 2023 | 992M 11.9M | Capitalization | 2.47B 29.65M |
|---|---|---|---|---|---|
| Net income 2022 | 34M 408K | Net income 2023 | 48M 576K | EV / Sales 2022 | 2.5 x |
| Net cash position 2022 | 181M 2.17M | Net cash position 2023 | 154M 1.85M | EV / Sales 2023 | 2.34 x |
| P/E ratio 2022 |
59.1
x | P/E ratio 2023 |
51.1
x | Employees | 632 |
| Yield 2022 * |
-
| Yield 2023 |
0.21% | Free-Float | 99% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.54% | ||
| 1 week | -13.16% | ||
| Current month | -16.60% | ||
| 1 month | -18.11% | ||
| 3 months | -22.73% | ||
| 6 months | -30.23% | ||
| Current year | -22.02% |
1 week
149.20
185.55
1 month
149.20200.00
Current year
149.20251.00
1 year
149.20376.95
3 years
98.00376.95
5 years
98.00376.95
10 years
98.00376.95
| Managers | Title | Age | Since |
|---|---|---|---|
Rohit Sane
FOU | Founder | - | 99-04-05 |
Rahul Mandole
CTO | Chief Tech/Sci/R&D Officer | 40 | - |
Gurudatta Amin
CTO | Chief Tech/Sci/R&D Officer | 40 | 14-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 57 | 21-08-31 | |
Rohit Sane
FOU | Founder | - | 99-04-05 |
| Chief Administrative Officer | 42 | 21-08-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-29 | 165 | -3.54% | 7 200 |
| 24-05-28 | 171 | -3.90% | 400 |
| 24-05-27 | 178 | -1.63% | 75,200 |
| 24-05-24 | 181 | -2.19% | 12,800 |
| 24-05-23 | 185 | -2.63% | 2,800 |
Delayed Quote NSE India S.E., May 29, 2024 at 05:07 am EDT
More quotes
Vaidya Sane Ayurved Laboratories Limited is an India-based company, which is engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines and products through its various franchises and own clinics. The Company is involved in providing ayurved medical professional services across its various clinics, including panchkarma and other ayurvedic treatments through the running of ayurvedic hospitals. It uses diagnostics, diet, physiotherapy and ayurveda to provide heart disease, diabetes, hypertension and obesity reversal treatments to its patients. The Company operates approximately 337 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, Haryana, Punjab, Himachal Pradesh, Uttarakhand, West Bengal, Jammu, Kerala, Orissa and Chhattisgarh. It owns about 55 clinics, 59 are OPD's and Mini Clinic and 223 are franchise clinics. The Company operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur.
Sector
Pharmaceuticals
Calendar
05:30am
- Q4 2024 Earnings Call
| 1st Jan change | Capi. | |
|---|---|---|
| -22.02% | 21.62M | |
| +42.07% | 6.23B | |
| -21.20% | 4.19B | |
| +5.38% | 3.32B | |
| -16.98% | 2.91B | |
| -5.82% | 2.42B | |
| +45.47% | 1.94B | |
| -12.67% | 1.59B | |
| -3.91% | 1.58B | |
| +44.56% | 1.49B |
- Stock Market
- Equities
- MADHAVBAUG Stock
